Sale of Shareholding in Avenir LNG Limited
Golar LNG Limited ('Golar') has entered into a share purchase agreement for the sale of all its shares in Avenir LNG Limited ('Avenir LNG' or 'Avenir') to Stolt-Nielsen Gas Ltd. for a total consideration of approximately USD 40 million (the 'Transaction'). The Transaction is expected to be completed during the first quarter of 2025, subject to fulfilment of the conditions under the share purchase agreement.
Golar will remain a 25% shareholder and debt provider to Higas Srl, the HIGAS LNG storage terminal in Sardinia, ('HIGAS') that was spun off from Avenir LNG in October 2024. As of end October 2024, the book value of HIGAS was USD 40.5 million (on a 100% basis), of which $24.7m was shareholder loans and $15.8m shareholders equity.
Golar CEO Karl-Fredrik Staubo commented: 'The sale of Golar's shareholding in Avenir LNG is in line with our strategy to focus on expanding our market leading FLNG position. Golar is proud to have founded Avenir LNG into one of the largest small-scale LNG shipping companies globally alongside our partners Stolt Nielsen and Höegh. Following the sale of Hygo Energy Transition Ltd. in 2021, our Avenir LNG investment was no longer deemed a core asset of Golar's portfolio. We wish the Avenir LNG team and Stolt-Nielsen all the best for the future development of Avenir.'
FORWARD LOOKING STATEMENTS
This press release contains forward-looking statements (as defined in Section 21E of the Securities Exchange Act of 1934, as amended) which reflect management's current expectations, estimates and projections about its operations. All statements, other than statements of historical facts, that address activities and events that will, should, could or may occur in the future are forward-looking statements. Words such as 'may,' 'could,' 'should,' 'would,' 'expect,' 'plan,' 'anticipate,' 'intend,' 'forecast,' 'believe,' 'estimate,' 'predict,' 'propose,' 'potential,' 'continue,' 'subject to' or the negative of these terms and similar expressions are intended to identify such forward-looking statements.
These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Golar LNG Limited undertakes no obligation to update publicly any forward-looking statements whether as a result of new information, future events or otherwise, unless required by applicable law.
Hamilton, Bermuda
Investor Questions: +44 207 063 7900
Karl Fredrik Staubo - CEO
Eduardo Maranhão - CFO
Stuart Buchanan - Head of Investor Relations
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Gradient Coils for MRI Systems Market Expected to Grow at a 7.5% CAGR Through 2034
Gradient Coils for MRI System Market: Forecast to 2034 Luton, Bedfordshire, United Kingdom, June 09, 2025 (GLOBE NEWSWIRE) -- The global gradient coils for MRI system market is witnessing substantial transformation, driven by a growing emphasis on early diagnostic imaging, advanced imaging quality, and the increasing adoption of AI technologies in healthcare. Estimated at USD 1.2 billion in 2024, the market is expected to reach around USD 2.5 billion by 2034, registering a CAGR of approximately 7.5% throughout the forecast period. This robust growth trajectory is fueled by both technological innovation and structural shifts in the healthcare landscape. Download PDF Brochure: Market Drivers and Growth Catalysts One of the primary drivers of this market is the increasing need for high-quality medical imaging, particularly for early diagnosis and personalized medicine. Gradient coils are integral to MRI systems, enhancing image quality and enabling precise scanning. The integration of artificial intelligence (AI) and machine learning technologies into MRI systems is further improving scan accuracy and reducing time, enhancing workflow efficiency and patient throughput. Additionally, the growing demand for compact and portable MRI systems is driving innovation in gradient coil designs. With the rise of outpatient and ambulatory surgical centers, there is a need for more flexible imaging solutions, resulting in increased demand for advanced gradient coils capable of delivering high performance in smaller, lightweight formats. Market Segmentation Overview The gradient coils market can be segmented based on product type, application, end user, technology, material, and distribution channel. By Product Type: Passive Gradient Coils Active Gradient Coils Active gradient coils dominate the market due to their superior performance in controlling field gradients and minimizing noise. They hold approximately 65% of the market share and are particularly favored in high-field MRI systems for their precision. By Application: Neurology Oncology Cardiology Musculoskeletal Others Neurology leads the application segment with a 35% share, attributed to increasing neurological disorder cases and the demand for high-resolution imaging. Oncology follows closely, fueled by innovations in cancer detection and therapy planning. By End User: Hospitals Diagnostic Imaging Centers Research Institutes Hospitals are the largest consumers, contributing nearly 50% to the market, thanks to their significant investments in MRI technology. Diagnostic imaging centers hold a 30% share, while research institutes play a vital role in fostering innovation. By Technology: Closed MRI Systems Open MRI Systems Closed MRI systems dominate with about 75% market share due to their higher imaging strength and application in hospital settings. However, open MRI systems are gaining traction among claustrophobic patients and pediatric use cases. By Material: Copper Aluminum Superconducting Materials Copper remains the most commonly used material due to its cost efficiency, accounting for about 60% of the market. However, superconducting materials are gaining momentum for their energy efficiency and performance benefits in high-end MRI systems. Browse full Report - Market Segmentation By Type - Passive Gradient Coils - Active Gradient Coils By Application - Neurology - Oncology - Cardiology - Musculoskeletal - Others By End-User - Hospitals - Diagnostic Imaging Centers - Research Institutes By Technology - Closed MRI Systems - Open MRI Systems By Material - Copper - Aluminum - Superconducting Materials Regional Insights North America leads the global market with a 45% revenue share in 2024, driven by advanced healthcare infrastructure, high R&D spending, and the presence of key industry players. The region is expected to grow at a CAGR of 6.5% through 2034. Europe holds around 30% market share, benefiting from universal healthcare coverage, public health investments, and strong demand for preventive diagnostics. Growth in the region is slightly slower, with a forecasted CAGR of 5.8%. Asia-Pacific is emerging as the fastest-growing region, with a projected CAGR of 8.2%. Increasing healthcare spending, medical reforms, and rising awareness of MRI technologies are key factors contributing to this growth. Rapid urbanization and expanding hospital networks in countries like China and India further support market expansion. Latin America and Middle East & Africa remain relatively smaller markets but are expected to grow steadily. Latin America is projected to grow at 3.5% CAGR, while MEA is forecasted at around 4.0%, driven by incremental infrastructure improvements and government healthcare initiatives. Challenges and Market Restraints Despite strong growth prospects, the market faces several obstacles. One major constraint is the high cost associated with MRI systems, including gradient coils. This limits adoption in cost-sensitive regions and small-scale healthcare facilities. Regulatory challenges also pose hurdles. Stringent approval processes for medical devices can delay product launches and increase costs for manufacturers. Furthermore, pricing pressures due to intense competition among market players often reduce profit margins, impacting R&D investment. Supply chain disruptions, highlighted during global crises like the COVID-19 pandemic, have also affected the availability of raw materials and components needed for gradient coil production. Delays in procurement and increased manufacturing costs can inhibit market stability. Emerging Opportunities and Trends New technological innovations and evolving business models are reshaping market dynamics. Companies are exploring alternative materials and improved coil designs to enhance energy efficiency and reduce device size. The demand for portable MRI units is fostering interest in lightweight, flexible gradient coils. Business models like MRI-as-a-Service (MraaS) are gaining momentum, offering healthcare facilities an affordable alternative to outright purchasing. This model allows recurring revenue for manufacturers and expands market access to mid-tier hospitals and rural centers. AI integration is another promising trend. As imaging software becomes more sophisticated, AI-driven optimization of gradient coil usage enhances image quality and reduces diagnostic errors. Partnerships between hardware providers and AI solution developers are expected to create next-gen MRI systems. Furthermore, the market is benefiting from the expansion of telehealth and remote diagnostics. These applications necessitate advanced imaging tools that can be used in decentralized or home-based settings, providing a promising avenue for compact MRI systems equipped with versatile gradient coils. Buy Now : Competitive Landscape Major players in the market include: Siemens Healthineers GE Healthcare Philips Healthcare Canon Medical Systems Hitachi Medical Systems Toshiba Medical Systems Varian Medical Systems Brainlab Shimadzu Corporation Esaote Agfa Healthcare Mindray Medical Fujifilm Holdings Neusoft Medical Systems United Imaging Healthcare Recent Developments In September 2023, Siemens Healthineers launched a new MRI system equipped with advanced gradient coils, designed to shorten scan times while improving image resolution. This innovation enhances operational efficiency and aligns with the growing need for faster diagnostics. In August 2023, GE Healthcare acquired a biotechnology firm specializing in MRI contrast agents. This acquisition enables GE to provide integrated imaging solutions, combining hardware and consumables, and positioning itself as a full-spectrum MRI provider. In July 2023, Philips Healthcare partnered with an AI technology firm to develop machine learning algorithms tailored for MRI diagnostics. The collaboration aims to enhance scanning accuracy and improve clinical decision-making. In June 2023, Canon Medical Systems received FDA approval for its latest MRI technology featuring next-gen gradient coils. This regulatory milestone strengthens Canon's foothold in the North American market and underlines its commitment to compliance and innovation. In May 2023, Mindray Medical introduced a new MRI system with enhanced gradient coil flexibility. The system is designed for lower-tier hospitals and developing markets, offering high performance at a lower cost, which expands access to premium diagnostic tools. This report is also available in the following languages : Japanese (MRIシステム向け傾斜磁場コイル市場), Korean (MRI 시스템 시장용 그래디언트 코일), Chinese (MRI系统梯度线圈市场), French (Bobines de gradient pour le marché des systèmes d'IRM), German (Gradientenspulen für den MRT-Systemmarkt), and Italian (Bobine di gradiente per il mercato dei sistemi MRI), etc. Request Sample Pages: More Research Finding – Fetal Magnetic Resonance Imaging System Market The global fetal magnetic resonance imaging (fMRI) system market is valued at approximately $150 million. This innovative imaging technology is essential for prenatal diagnostics, providing non-invasive insights into fetal development. The market is projected to reach around $350 million by 2034, driven by advancements in MRI technology and increasing awareness of prenatal health. Magnetic Resonance Imaging Gradient Coil Market The global market for Magnetic Resonance Imaging (MRI) Gradient Coils is valued at approximately $1.5 billion in 2024, driven by increasing demand for advanced imaging technologies and rising incidences of chronic diseases requiring precise diagnostics. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.5%, reaching an estimated value of $3.1 billion by 2034. RF Coil for MRI System Market The RF coil market for MRI systems is valued at approximately $1.2 billion in 2024, with projections indicating a surge to around $2.2 billion by 2034. This represents a robust Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period from 2025 to 2034. Superconducting Magnet for Medical MRI System Market The global superconducting magnet market for medical MRI systems was valued at approximately $2.5 billion in 2024, with projections suggesting a growth to around $4.5 billion by 2034. This represents a robust Compound Annual Growth Rate (CAGR) of about 6.5% during the forecast period from 2025 to 2034. Superconducting MRI System Market The global superconducting MRI system market is poised to reach a value of approximately $6.8 billion in 2024, driven by advancements in imaging technologies and a growing focus on precision medicine. The market is projected to expand robustly, anticipating a compound annual growth rate (CAGR) of around 5.6% from 2025 to 2034, potentially escalating to over $10 billion by the end of this forecast period. MR Neuro Imaging Market The global MR neuroimaging market is projected to reach a value of approximately $5.1 billion in 2024, driven by advancements in imaging technologies, increasing incidence of neurological disorders, and growing demand for non-invasive diagnostic tools. Forecasted growth for the period 2025–2034 points to a market value of around $8.4 billion, reflecting a compound annual growth rate (CAGR) of approximately 5.1%. Superconducting Magnets MRI Systems Market The global superconducting magnets MRI systems market is valued at approximately $4.5 billion in 2024, with expectations for robust growth, poised to reach around $7.5 billion by 2034. This represents a compound annual growth rate (CAGR) of 5.2% from 2025 to 2034. VXR Veterinary Radiological System Market The global VXR veterinary radiological systems market is valued at approximately $650 million, driven by an increased focus on advanced diagnostic imaging techniques in veterinary medicine. The market is projected to achieve a value of $1.2 billion by 2034, reflecting the growing demand for sophisticated radiological technologies and the rising prevalence of pet diseases. This represents a Compound Annual Growth Rate (CAGR) of around 6.3% during the forecast period (2025–2034). Diagnostic Medical Imaging Equipment Market The global diagnostic medical imaging equipment market is projected to reach a value of approximately $49 billion in 2024, reflecting a significant surge driven by advancements in technology and increasing healthcare expenditure. The market is anticipated to grow at a Compound Annual Growth Rate (CAGR) of around 7.5% from 2025 to 2034, reaching an estimated value of $95 billion by the end of the forecast period. Superconducting Magnetic Resonance Imaging System Market The global superconducting magnetic resonance imaging (MRI) system market is valued at approximately $7.5 billion in 2024, with projections estimating growth to around $12 billion by 2034. This indicates a robust Compound Annual Growth Rate (CAGR) of about 5% during the forecast period from 2025 to 2034. Mobile Scan Radiology Room Market The global mobile scan radiology room market is valued at approximately $5 billion in 2024, with projections indicating a robust growth trajectory leading to an estimated market value of $8.5 billion by 2034. This represents a Compound Annual Growth Rate (CAGR) of around 6.0% during the forecast period from 2025 to 2034. Medical Magnetic Resonance Imaging MRI Equipment Market The global market for medical magnetic resonance imaging (MRI) equipment is valued at approximately $6.5 billion. The market is anticipated to grow significantly, with projections showing a value of around $9.8 billion by 2034, representing a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period from 2025 to 2034. MRI Systems Devices Market The global MRI systems market is valued at approximately $7.2 billion, with expectations of reaching $11.5 billion by 2034, driven by technological advancements and increasing demand for diagnostic imaging. The market is projected to witness a Compound Annual Growth Rate (CAGR) of approximately 4.7% during the forecast period from 2025 to 2034. U.S. Preclinical Imaging Market The U.S. preclinical imaging market is estimated to be valued at approximately $2.4 billion in 2024, with growth projected to reach around $4.5 billion by 2034. This growth corresponds to a Compound Annual Growth Rate (CAGR) of approximately 6.7% during the forecast period from 2025 to 2034. U.S. Digital Radiology Devices Market The U.S. digital radiology devices market is valued at approximately $4.7 billion, driven by advancements in imaging technologies and increased demand for diagnostic imaging. The projected market value for 2034 is expected to reach around $8.6 billion, reflecting a robust growth trajectory. This translates to a Compound Annual Growth Rate (CAGR) of about 6.3% from 2025 to 2034. Digital Radiology Devices Market The digital radiology devices market is valued at approximately $10.5 billion in 2024, with significant growth expected over the forecast period of 2025 to 2034, projected to reach around $18.6 billion. This growth reflects a compound annual growth rate (CAGR) of about 6.2%. Magnetic Resonance Imaging Scanners Market The global magnetic resonance imaging scanners market is anticipated to grow from USD 7.72 Billion in 2023 to USD 11.96 Billion by 2030, at a CAGR of 6.45 % during the forecast period. CONTACT: Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28 minutes ago
- Yahoo
Isobutyric Acid Market to Reach USD 356.84 million by 2032
Growing use in sustainable bio-based chemicals drives Isobutyric Acid demand; expanding applications in nutraceutical formulations boost market growth. Austin, June 09, 2025 (GLOBE NEWSWIRE) -- The Isobutyric Acid Market Size was valued at USD 197.35 million in 2024 and is expected to reach USD 356.84 million by 2032, growing at a CAGR of 7.69% over the forecast period of 2025-2032. Expansion of Green Chemistry and Health-Focused Manufacturing Drives the Multifaceted Growth of the Global Isobutyric Acid Industry The Isobutyric Acid market is growing steadily due to its wide use in pharmaceuticals, food flavorings, and chemical intermediates like vitamins and plasticizers. Regulatory backing from the U.S. FDA and the USDA's push for renewable chemicals are boosting confidence. Companies such as BASF and Eastman Chemical are expanding capacities to meet demand. Rising interest in natural ingredients and advances in synthetic production are improving quality and affordability. Biotechnology investments are further driving innovation, ensuring sustained growth across various industrial PDF Sample of Isobutyric Acid Market @ The U.S. Isobutyric Acid Market had the largest market share of 77% in 2024, with a market size of USD 51.63 million. The U.S. Isobutyric Acid market is growing steadily, driven by pharmaceutical industry expansion and consumer preference for health-focused ingredients. FDA's encouragement of bio-based chemicals and companies like DuPont introducing bio-derived Isobutyric Acid derivatives support this growth, bolstered by rising healthcare product innovations. Key Players: Eastman Chemical Company OQ Chemicals GmbH Dow Inc. Evonik Industries AG AFYREN Jiangsu Dynamic Chemical Co., Ltd. Tokyo Chemical Industry Co., Ltd. Weifang Qiyi Chemical Co., Ltd. Shanghai Aladdin Biochemical Technology Co., Ltd. Hubei Jusheng Technology Co., Ltd. Isobutyric Acid Market Report Scope: Report Attributes Details Market Size in 2024 USD 197.35 million Market Size by 2032 USD 356.84 million CAGR CAGR of 7.69% From 2025 to 2032 Base Year 2024 Forecast Period 2025-2032 Historical Data 2021-2023 Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook Key Drivers • Expansion of Bio-Based Production Facilities Enhances Isobutyric Acid Market Growth.• Rising Demand for Pharmaceutical-Grade Isobutyric Acid Fuels Market Expansion. If You Need Any Customization on Isobutyric Acid Market Report, Inquire Now @ By Type, Synthetic Isobutyric Acid Dominated the Isobutyric Acid Market in 2024 with a 68.5% Market Share. This dominance is due to its cost-efficiency, high purity, and consistent quality, meeting industry standards for pharmaceuticals and chemicals. Its scalable production suits large-volume applications like plasticizers and solvents. Eastman Chemical's Tennessee facility saw a 12% output rise in 2023 to meet growing demand. While renewable Isobutyric Acid is gaining interest, it currently trails due to higher costs and limited scalability. However, investments in bio-fermentation technologies indicate promising future growth for the renewable segment. By End-use, the Pharmaceutical Application dominated the Isobutyric Acid Market in 2024 with a 31.6% Market Share. The dominance is due to Isobutyric Acid's vital role in drug synthesis, including beta-blockers and vitamin E derivatives. FDA approvals and increased R&D have expanded its use, with companies like Pfizer and Johnson & Johnson relying heavily on it. Growing global demand for advanced therapies and personalized medicine drives further growth. While food & flavor and animal feed sectors contribute, they remain secondary due to more specialized applications, reinforcing pharmaceuticals as the primary driver of market dominance. North America dominated the Isobutyric Acid Market in 2024, Holding a 34.2% Market Share. North America leads the Isobutyric Acid market due to its advanced pharmaceutical and chemical industries, strong R&D investments, and strict regulatory standards. U.S. companies like BASF and Eastman Chemical have expanded production to meet rising demand. Government initiatives supporting bio-based chemicals have boosted renewable Isobutyric Acid development. Additionally, top research institutions and biotech firms drive innovation, strengthening the region's leadership in product development and global supply, and securing its position as the leading contributor to the global Isobutyric Acid market. Asia Pacific is the fastest-growing region in the Isobutyric Acid Market in 2024, holding the Highest CAGR of 9.37%. Asia Pacific's growth in the Isobutyric Acid market is driven by rapid industrialization, expanding pharmaceutical production, and increasing consumer awareness. China and India are investing heavily in chemical infrastructure, backed by green chemistry incentives. Rising demand from the food flavoring and personal care sectors further boosts the market. Chinese firms have introduced Isobutyric Acid-infused flavorings, widely used in beverages. Collaborations between Asian manufacturers and Western tech providers are enhancing product quality and efficiency, accelerating regional market Full Research Report @ About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Business Wire
41 minutes ago
- Business Wire
Sobot Reveals 'AI-First' Strategy for Delivering Human-Like Customer Service
NEW YORK--(BUSINESS WIRE)--Sobot, a leading AI customer contact solution provider, unveiled its 'AI-First' strategy at a media launch event this month. The move elevates Sobot AI with five pillars, including Omnichannel AI, Scenario-Based AI, Multi-Faceted AI, Generative AI and Secure AI to create an experience-led, easy-to-use, and efficiency-driven solution. Redefine the next-gen AI customer service platform. Share Sobot Aims to Deliver Intelligent yet More Human-like Service AI has quickly become central to digital transformation in customer service. According to MarketsandMarkets, the global AI-for-customer-service market was valued at USD 12.06 billion in 2024 and is projected to reach USD 47.82 billion by 2030. Yet 52% of customers prefer human interaction for its empathy, while another 42% favor a blend of AI and human support. While some customers find AI insufficiently human, its adoption in customer service is now irreversible. Customer service solution providers must therefore balance customer expectations with the power of AI. 'Fed up with limited contextual comprehension, inflexible responses, and poor emotional perception, customers want their needs understood and met,' said Yi Xu, CEO of Sobot. 'Our 'AI-First' strategy doesn't just automate processes; it aims to provide intelligent but more human-like services.' Highlight of Sobot's AI-First Strategy: Five Pillars of Next-Gen AI Omnichannel AI - Ensuring Seamless, Efficient Experience Across All Channels Sobot AI integrates websites, mobile apps, social platforms such as Facebook, Instagram and WhatsApp, plus email, phone calls and SMS. Beyond online chat, it includes AI voicebot that can handle inbound and outbound calls. Sobot AI also unifies and connects information of all channels, giving customers a seamless experience wherever they start. Scenario-Based AI - Providing Industry-Specific Solutions Sobot AI is never limited to fixed functions, it keeps upgrading and extending, making it suitable for various industries. Designed especially for retail and e-commerce, Sobot AI spans the entire purchase journey. It answers pre-sales inquiries 24/7, converting browsers into buyers; it sends personalized recommendations during checkout to increase the sales volume; it resolves post-sales issues quickly to boost customer satisfaction. Multi-Faceted AI - Supporting Customers, Agents and Administrators Sobot AI supports multiple roles during the process of customer service. For customers, Sobot AI Agent learns from the knowledge base to deliver accurate, humanized service. For human agents, Sobot AI Copilot suggests replies and drafts summaries, raising efficiency. For administrators, Sobot AI Insight supplies detailed dashboards to optimize operations. Generative AI - Combining Multiple Advanced LLMs and SLMs Powered by leading LLMs (Large Language Models) such as OpenAI and DeepSeek, Sobot AI boasts powerful generative capacity able to decompose knowledge, retrieve the most relevant content, and intelligently composes accurate responses. Sobot AI is also powered by several SLMs (Small Language Models), which is helpful to create industry-oriented solutions, enhancing the accuracy and professionalism of customer service. Secure AI - Guaranteeing Global Data Privacy and Compliance Sobot aligns its platform with country-specific regulations and holds a number of internationally recognized certifications in information, cloud, and system security. Regional data centers in the United States, Europe, Singapore, and other locations ensure reliable performance worldwide. Sobot is Committed to Reshaping Customer Service with Humanized AI Alongside its 'AI-First' strategy, Sobot has refreshed its website, especially the AI Solution page so customers can easily learn more about the basic features, use cases, benefits, and more of Sobot AI. And just as what is shown in its website, Sobot's new generation of AI is committed to creating 'experience-led, easy-to-use and efficiency-driven AI for CX'. Xu added, 'Our strategy prioritizes customer experience, but it is equally valuable for businesses. The five pillars are its cornerstone, yet their essence is humanization. Sobot will continue to practice this vision, helping more customers and companies reshape service through humanized AI.' For more information, please visit
